Opioids Market Size and Forecast (2021-2031)

According to our new research study on “Opioids Market Forecast to 2031 – Global Analysis – by Products, Application, Route of administration, Distribution Channel, and Geography,” the market is expected to grow from US$ 12.93 billion in 2023 to US$ 15.03 billion by 2031; it is anticipated to record a CAGR of 1.9% from 2023 to 2031. The report emphasizes the trends prevalent in the global market, and drivers and deterrents affecting its growth. The surging prevalence of chronic pain followed by increasing geriatric population propel the opioids market growth. However, increasing drug abuse restrict the market growth. government initiatives focusing on development of medication to prevent and treat opioid overdose and disorder are expected to bring opioids market trends in the coming years.

Strategic Initiatives by Market Players to Create Growth Opportunities in Opioids Market

Opioids market players invest in R&D activities to ensure the development of effective products. In May 2023, Indivior PLC received the US Food and Drug Administration (FDA) approval for OPVEE (nalmefene) nasal spray for emergency use to treat suspected or known opioid overdose induced by synthetic or natural opioids in adults and pediatric patients aged 12 years and more, which is characterized by the central nervous system (CNS) and/or respiratory depression. In December 2021, Sandoz announced the launch of its generic Narcan (naloxone hydrochloride) Nasal Spray 4mg in the US; the product is used to reverse opioid overdose. Individuals in the US can immediately obtain Narcan via retail pharmacies and institutions, including hospitals. In August 2023, Emergent BioSolutions launched the over-the-counter NARCAN Nasal Spray, making it possible for everybody to help save a life from an opioid overdose emergency.

Opioids Market, by Region, 2023(%)

Source: the Research Team Analysis

Therefore, strategic initiatives are likely to offer growth opportunities to the opioids market in the coming years.

The opioids market is segmented on the basis of product, application, route of administration, distribution channel, and geography. In terms of product, the market is segmented into immediate-release short-acting opioids and extended-release long-acting opioids. In 2023, the immediate-release short-acting opioid segment held a larger opioids market share in 2023. It is further anticipated to register a higher CAGR of 2.0% in the market during the forecast period.

The opioids market, by application, is segmented into pain management, anesthesia, diarrhea suppression, cough suppression, de-addiction, and others. The pain management held the largest share of the market in 2023. The de-addiction segment is anticipated to register the highest CAGR of 2.4% during the forecast period. The pain management segment contributed largest to the opioids market growth, in terms of revenue share, in 2023, and it is expected to account for 71.70% of the market by 2031.

In terms of the route of administration, the opioid market is segmented into oral, injectables, and patches. The oral segment held the largest share of the market in 2023. However, the transdermal patches segment is anticipated to register the highest CAGR of 2.5% is during the forecast period.

Based on distribution channel, the market is bifurcated into hospital pharmacies and retail pharmacies. The hospital pharmacies segment held a larger share of the market in 2023. It is estimated to record a higher CAGR of 2.1% during the forecast period. Hospital pharmacists are responsible for monitoring opioid prescriptions, verifying dosages, and providing education to healthcare providers and patients based on the risks and benefits of the therapy. Additionally, hospital pharmacies may implement protocols to prevent opioid diversion and misuse within healthcare facilities. With the increasing opioid use, hospital pharmacies are highly focused on promoting responsible opioid prescription practices and implementing strategies to minimize the risk of opioid-related harm among patients. They engage in collaborative efforts with healthcare providers and regulatory agencies to ensure the effective and safe use of opioids in hospital settings Thus, the increasing number of admissions in hospitals is likely to drive the sales of opioids in hospital pharmacies.

Purdue Pharma LP, Endo International plc, Mallinckrodt Plc, Collegium Pharmaceutical Inc, Neuraxpharm Pharmaceuticals SL, Hikma Pharmaceuticals Plc, Mayne Pharma Group Ltd, Rusan Pharma Ltd, Trevena Inc, and Teva Pharmaceutical Industries Ltd are among the prominent players profiled in the opioids market report. In addition, several other players have been studied and analyzed during the study to get a holistic view of the market and its ecosystem. These companies focus on geographic expansions and new product launches to meet the growing demand from consumers worldwide and increase their product range in specialty portfolios. These initiatives by the companies are expected to bolster the opioids market size during the forecast period.

The opioids market analysis has been carried out by considering the following segments: product type, application, route of administration, distribution channel, and geography. The opioids market, by type, is segmented into immediate-release short-acting opioids and extended-release long-acting opioids. Based on application, the opioid market is segmented into pain management, anesthesia, diarrhea suppression, cough suppression, de-addiction, and others. Based on the route of administration, the opioid market is segmented into oral, injectables, and patches. Based on distribution channel, the market is further divided into hospital pharmacies and retail pharmacies. The geographic scope of the opioids market report encompasses North America (US, Canada, and Mexico), Europe (Spain, UK, Germany, France, Italy, and Rest of Europe), Asia Pacific (South Korea, China, India, Japan, Australia, and Rest of Asia Pacific), Middle East & Africa (UAE, Saudi Arabia, South Africa, and Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and Rest of South & Central America).

Contact Us

Contact Person: Sameer Joshi

Phone: +1-646-491-9876

Email Id: sales@theinsightpartners.com

1. Introduction
1.1 the Research Team Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Opioids Market Landscape
4.1 Overview
4.2 PEST Analysis
5. Opioids Market – Key Market Dynamics
5.1 Opioids Market – Key Market Dynamics
5.2 Market Drivers
5.2.1 Surging Chronic Pain Incidence
5.2.2 Increasing Geriatric Population
5.3 Market Restraints
5.3.1 Increasing Drug Abuse
5.4 Market Opportunities
5.4.1 Strategic Initiatives by Market Players
5.5 Future Trends
5.5.1 Government Initiatives Focusing on Development of Medication to Prevent and Treat Opioid Overdose and Disorder
5.6 Impact of Drivers and Restraints:
6. Opioids Market – Global Market Analysis
6.1 Opioids Market Revenue (US$ Million), 2022–2030
6.2 Opioids Market Forecast Analysis
7. Opioids Market Analysis – by Product
7.1 Immediate Release Short Acting Opioid
7.1.1 Overview
7.1.2 Immediate Release Short Acting Opioid: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
7.1.2.1 Global Opioids Market – Revenue and Forecast to 2030 (US$ Million) – by Immediate Release Short Acting Opioid
7.2 Extended Release Long-Acting Opioid
7.2.1 Overview
7.2.2 Extended Release Long-Acting Opioid: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
7.2.2.1 Global Opioids Market – Revenue and Forecast to 2030 (US$ Million) – by Extended Release Long-Acting Opioid
8. Opioids Market Analysis – by Application
8.1 Pain Management
8.1.1 Overview
8.1.2 Pain Management: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
8.2 Anesthesia
8.2.1 Overview
8.2.2 Anesthesia: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
8.3 Diarrhoea Suppression
8.3.1 Overview
8.3.2 Diarrhoea Suppression: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Cough Suppression
8.4.1 Overview
8.4.2 Cough Suppression: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
8.5 De-Addiction
8.5.1 Overview
8.5.2 De-Addiction: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
8.6 Others
8.6.1 Overview
8.6.2 Others: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
9. Opioids Market Analysis – by Route of Administration
9.1 Oral
9.1.1 Overview
9.1.2 Oral: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
9.2 Injectable
9.2.1 Overview
9.2.2 Injectable: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
9.3 Transdermal Patch
9.3.1 Overview
9.3.2 Transdermal Patch: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
10. Opioids Market Analysis – by Distribution Channel
10.1 Hospital Pharmacies
10.1.1 Overview
10.1.2 Hospital Pharmacies: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
10.2 Retail Pharmacies
10.2.1 Overview
10.2.2 Retail Pharmacies: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
11. Opioids Market – Geographical Analysis
11.1 Overview
11.2 North America
11.2.1 North America Opioids Market Overview
11.2.2 North America: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
11.2.2.1 North America: Opioids Market – Revenue and Forecast Analysis – by Product
11.2.3 North America: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
11.2.3.1 North America: Opioids Market – Revenue and Forecast Analysis – by Immediate Release Short Acting Opioid
11.2.3.2 North America: Opioids Market – Revenue and Forecast Analysis – by Extended Release Long-Acting Opioid
11.2.3.3 North America: Opioids Market – Revenue and Forecast Analysis – by Application
11.2.4 North America: Opioids Market Breakdown, by Route of Administration
11.2.4.1 North America: Opioids Market – Revenue and Forecast Analysis – by Route of Administration
11.2.4.2 North America: Opioids Market – Revenue and Forecast Analysis – by Distribution Channel
11.2.5 North America: Opioids Market – Revenue and Forecast Analysis – by Country
11.2.5.1 North America: Opioids Market – Revenue and Forecast Analysis – by Country
11.2.5.2 United States: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
11.2.5.2.1 United States: Opioids Market Breakdown, by Product
11.2.5.2.2 United States: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
11.2.5.2.3 United States: Opioids Market Breakdown, by Extended Release Long-Acting Opioid
11.2.5.2.4 United States: Opioids Market Breakdown, by Application
11.2.5.2.5 United States: Opioids Market Breakdown, by Route of Administration
11.2.5.2.6 United States: Opioids Market Breakdown, by Distribution Channel
11.2.5.3 Canada: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
11.2.5.3.1 Canada: Opioids Market Breakdown, by Product
11.2.5.3.2 Canada: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
11.2.5.3.3 Canada: Opioids Market Breakdown, by Extended Release Long-Acting Opioid
11.2.5.3.4 Canada: Opioids Market Breakdown, by Application
11.2.5.3.5 Canada: Opioids Market Breakdown, by Route of Administration
11.2.5.3.6 Canada: Opioids Market Breakdown, by Distribution Channel
11.2.5.4 Mexico: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
11.2.5.4.1 Mexico: Opioids Market Breakdown, by Product
11.2.5.4.2 Mexico: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
11.2.5.4.3 Mexico: Opioids Market Breakdown, by Extended Release Long-Acting Opioid
11.2.5.4.4 Mexico: Opioids Market Breakdown, by Application
11.2.5.4.5 Mexico: Opioids Market Breakdown, by Route of Administration
11.2.5.4.6 Mexico: Opioids Market Breakdown, by Distribution Channel
11.3 Europe
11.3.1 Europe Opioids Market Overview
11.3.2 Europe: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
11.3.3 Europe: Opioids Market Breakdown, by Product
11.3.3.1 Europe: Opioids Market – Revenue and Forecast Analysis – by Product
11.3.3.2 Europe: Opioids Market – Revenue and Forecast Analysis – by Immediate Release Short Acting Opioid
11.3.3.3 Europe: Opioids Market – Revenue and Forecast Analysis – by Extended Release Long-Acting Opioid
11.3.3.4 Europe: Opioids Market – Revenue and Forecast Analysis – by Application
11.3.3.5 Europe: Opioids Market – Revenue and Forecast Analysis – by Route of Administration
11.3.3.6 Europe: Opioids Market – Revenue and Forecast Analysis – by Distribution Channel
11.3.4 Europe: Opioids Market – Revenue and Forecast Analysis – by Country
11.3.4.1 Europe: Opioids Market – Revenue and Forecast Analysis – by Country
11.3.4.2 United Kingdom: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
11.3.4.2.1 United Kingdom: Opioids Market Breakdown, by Product
11.3.4.2.2 United Kingdom: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
11.3.4.2.3 United Kingdom: Opioids Market Breakdown, by Extended Release Long-Acting Opioid
11.3.4.2.4 United Kingdom: Opioids Market Breakdown, by Application
11.3.4.2.5 United Kingdom: Opioids Market Breakdown, by Route of Administration
11.3.4.2.6 United Kingdom: Opioids Market Breakdown, by Distribution Channel
11.3.4.3 Germany: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
11.3.4.3.1 Germany: Opioids Market Breakdown, by Product
11.3.4.3.2 Germany: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
11.3.4.3.3 Germany: Opioids Market Breakdown, by Extended Release Long-Acting Opioid
11.3.4.3.4 Germany: Opioids Market Breakdown, by Application
11.3.4.3.5 Germany: Opioids Market Breakdown, by Route of Administration
11.3.4.3.6 Germany: Opioids Market Breakdown, by Distribution Channel
11.3.4.4 France: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
11.3.4.4.1 France: Opioids Market Breakdown, by Product
11.3.4.4.2 France: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
11.3.4.4.3 France: Opioids Market Breakdown, by Extended Release Long-Acting Opioid
11.3.4.4.4 France: Opioids Market Breakdown, by Application
11.3.4.4.5 France: Opioids Market Breakdown, by Route of Administration
11.3.4.4.6 France: Opioids Market Breakdown, by Distribution Channel
11.3.4.5 Italy: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
11.3.4.5.1 Italy: Opioids Market Breakdown, by Product
11.3.4.5.2 Italy: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
11.3.4.5.3 Italy: Opioids Market Breakdown, by Extended Release Long-Acting Opioid
11.3.4.5.4 Italy: Opioids Market Breakdown, by Application
11.3.4.5.5 Italy: Opioids Market Breakdown, by Route of Administration
11.3.4.5.6 Italy: Opioids Market Breakdown, by Distribution Channel
11.3.4.6 Spain: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
11.3.4.6.1 Spain: Opioids Market Breakdown, by Product
11.3.4.6.2 Spain: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
11.3.4.6.3 Spain: Opioids Market Breakdown, by Extended Release Long-Acting Opioid
11.3.4.6.4 Spain: Opioids Market Breakdown, by Application
11.3.4.6.5 Spain: Opioids Market Breakdown, by Route of Administration
11.3.4.6.6 Spain: Opioids Market Breakdown, by Distribution Channel
11.3.4.7 Rest of Europe: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
11.3.4.7.1 Rest of Europe: Opioids Market Breakdown, by Product
11.3.4.7.2 Rest of Europe: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
11.3.4.7.3 Rest of Europe: Opioids Market Breakdown, by Extended Release Long-Acting Opioid
11.3.4.7.4 Rest of Europe: Opioids Market Breakdown, by Application
11.3.4.7.5 Rest of Europe: Opioids Market Breakdown, by Route of Administration
11.3.4.7.6 Rest of Europe: Opioids Market Breakdown, by Distribution Channel
11.4 Asia Pacific
11.4.1 Asia Pacific Opioids Market Overview
11.4.2 Asia Pacific: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
11.4.2.1 Asia Pacific: Opioids Market – Revenue and Forecast Analysis – by Product
11.4.2.2 Asia Pacific: Opioids Market – Revenue and Forecast Analysis – by Immediate Release Short Acting Opioid
11.4.2.3 Asia Pacific: Opioids Market – Revenue and Forecast Analysis – by Extended Release Long-Acting Opioid
11.4.2.4 Asia Pacific: Opioids Market – Revenue and Forecast Analysis – by Application
11.4.2.5 Asia Pacific: Opioids Market – Revenue and Forecast Analysis – by Route of Administration
11.4.2.6 Asia Pacific: Opioids Market – Revenue and Forecast Analysis – by Distribution Channel
11.4.3 Asia Pacific: Opioids Market – Revenue and Forecast Analysis – by Country
11.4.3.1 Asia Pacific: Opioids Market – Revenue and Forecast Analysis – by Country
11.4.3.2 China: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
11.4.3.2.1 China: Opioids Market Breakdown, by Product
11.4.3.2.2 China: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
11.4.3.2.3 China: Opioids Market Breakdown, by Extended Release Long-Acting Opioid
11.4.3.2.4 China: Opioids Market Breakdown, by Application
11.4.3.2.5 China: Opioids Market Breakdown, by Route of Administration
11.4.3.2.6 China: Opioids Market Breakdown, by Distribution Channel
11.4.3.3 Japan: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
11.4.3.3.1 Japan: Opioids Market Breakdown, by Product
11.4.3.3.2 Japan: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
11.4.3.3.3 Japan: Opioids Market Breakdown, by Extended Release Long-Acting Opioid
11.4.3.3.4 Japan: Opioids Market Breakdown, by Application
11.4.3.3.5 Japan: Opioids Market Breakdown, by Route of Administration
11.4.3.3.6 Japan: Opioids Market Breakdown, by Distribution Channel
11.4.3.4 India: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
11.4.3.4.1 India: Opioids Market Breakdown, by Product
11.4.3.4.2 India: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
11.4.3.4.3 India: Opioids Market Breakdown, by Extended Release Long-Acting Opioid
11.4.3.4.4 India: Opioids Market Breakdown, by Application
11.4.3.4.5 India: Opioids Market Breakdown, by Route of Administration
11.4.3.4.6 India: Opioids Market Breakdown, by Distribution Channel
11.4.3.5 South Korea: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
11.4.3.5.1 South Korea: Opioids Market Breakdown, by Product
11.4.3.5.2 South Korea: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
11.4.3.5.3 South Korea: Opioids Market Breakdown, by Extended Release Long-Acting Opioid
11.4.3.5.4 South Korea: Opioids Market Breakdown, by Application
11.4.3.5.5 South Korea: Opioids Market Breakdown, by Route of Administration
11.4.3.5.6 South Korea: Opioids Market Breakdown, by Distribution Channel
11.4.3.6 Australia: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
11.4.3.6.1 Australia: Opioids Market Breakdown, by Product
11.4.3.6.2 Australia: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
11.4.3.6.3 Australia: Opioids Market Breakdown, by Extended Release Long-Acting Opioid
11.4.3.6.4 Australia: Opioids Market Breakdown, by Application
11.4.3.6.5 Australia: Opioids Market Breakdown, by Route of Administration
11.4.3.6.6 Australia: Opioids Market Breakdown, by Distribution Channel
11.4.3.7 Rest of APAC: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
11.4.3.7.1 Rest of APAC: Opioids Market Breakdown, by Product
11.4.3.7.2 Rest of APAC: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
11.4.3.7.3 Rest of APAC: Opioids Market Breakdown, by Extended Release Long-Acting Opioid
11.4.3.7.4 Rest of APAC: Opioids Market Breakdown, by Application
11.4.3.7.5 Rest of APAC: Opioids Market Breakdown, by Route of Administration
11.4.3.7.6 Rest of APAC: Opioids Market Breakdown, by Distribution Channel
11.5 Middle East and Africa
11.5.1 Middle East and Africa Opioids Market Overview
11.5.2 Middle East and Africa: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
11.5.2.1 Middle East and Africa: Opioids Market – Revenue and Forecast Analysis – by Product
11.5.2.2 Middle East and Africa: Opioids Market – Revenue and Forecast Analysis – by Immediate Release Short Acting Opioid
11.5.2.3 Middle East and Africa: Opioids Market – Revenue and Forecast Analysis – by Extended Release Long-Acting Opioid
11.5.2.4 Middle East and Africa: Opioids Market – Revenue and Forecast Analysis – by Application
11.5.2.5 Middle East and Africa: Opioids Market – Revenue and Forecast Analysis – by Route of Administration
11.5.2.6 Middle East and Africa: Opioids Market – Revenue and Forecast Analysis – by Distribution Channel
11.5.2.7 Middle East and Africa: Opioids Market – Revenue and Forecast Analysis – by Country
11.5.2.8 Saudi Arabia: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
11.5.2.8.1 Saudi Arabia: Opioids Market Breakdown, by Product
11.5.2.8.2 Saudi Arabia: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
11.5.2.8.3 Saudi Arabia: Opioids Market Breakdown, by Extended Release Long Acting Opioid
11.5.2.8.4 Saudi Arabia: Opioids Market Breakdown, by Application
11.5.2.8.5 Saudi Arabia: Opioids Market Breakdown, by Route Of Administration
11.5.2.8.6 Saudi Arabia: Opioids Market Breakdown, by Distribution Channel
11.5.2.9 South Africa: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
11.5.2.9.1 South Africa: Opioids Market Breakdown, by Product
11.5.2.9.2 South Africa: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
11.5.2.9.3 South Africa: Opioids Market Breakdown, by Extended Release Long Acting Opioid
11.5.2.9.4 South Africa: Opioids Market Breakdown, by Application
11.5.2.9.5 South Africa: Opioids Market Breakdown, by Route Of Administration
11.5.2.9.6 South Africa: Opioids Market Breakdown, by Distribution Channel
11.5.2.10 United Arab Emirates: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
11.5.2.10.1 United Arab Emirates: Opioids Market Breakdown, by Product
11.5.2.10.2 United Arab Emirates: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
11.5.2.10.3 United Arab Emirates: Opioids Market Breakdown, by Extended Release Long Acting Opioid
11.5.2.10.4 United Arab Emirates: Opioids Market Breakdown, by Application
11.5.2.10.5 United Arab Emirates: Opioids Market Breakdown, by Route Of Administration
11.5.2.10.6 United Arab Emirates: Opioids Market Breakdown, by Distribution Channel
11.5.2.11 Rest of Middle East and Africa: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
11.5.2.11.1 Rest of Middle East and Africa: Opioids Market Breakdown, by Product
11.5.2.11.2 Rest of Middle East and Africa: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
11.5.2.11.3 Rest of Middle East and Africa: Opioids Market Breakdown, by Extended Release Long Acting Opioid
11.5.2.11.4 Rest of Middle East and Africa: Opioids Market Breakdown, by Application
11.5.2.11.5 Rest of Middle East and Africa: Opioids Market Breakdown, by Route Of Administration
11.5.2.11.6 Rest of Middle East and Africa: Opioids Market Breakdown, by Distribution Channel
11.6 South and Central America
11.6.1 South and Central America Opioids Market Overview
11.6.2 South and Central America: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
11.6.2.1 South and Central America: Opioids Market – Revenue and Forecast Analysis – by Product
11.6.2.2 South and Central America: Opioids Market – Revenue and Forecast Analysis – by Immediate Release Short Acting Opioid
11.6.2.3 South and Central America: Opioids Market – Revenue and Forecast Analysis – by Extended Release Long Acting Opioid
11.6.2.4 South and Central America: Opioids Market – Revenue and Forecast Analysis – by Application
11.6.2.5 South and Central America: Opioids Market – Revenue and Forecast Analysis – by Route Of Administration
11.6.2.6 South and Central America: Opioids Market – Revenue and Forecast Analysis – by Distribution Channel
11.6.3 South and Central America: Opioids Market – Revenue and Forecast Analysis – by Country
11.6.3.1 South and Central America: Opioids Market – Revenue and Forecast Analysis – by Country
11.6.3.2 Brazil: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
11.6.3.2.1 Brazil: Opioids Market Breakdown, by Product
11.6.3.2.2 Brazil: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
11.6.3.2.3 Brazil: Opioids Market Breakdown, by Extended Release Long Acting Opioid
11.6.3.2.4 Brazil: Opioids Market Breakdown, by Application
11.6.3.2.5 Brazil: Opioids Market Breakdown, by Route Of Administration
11.6.3.2.6 Brazil: Opioids Market Breakdown, by Distribution Channel
11.6.3.3 Argentina: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
11.6.3.3.1 Argentina: Opioids Market Breakdown, by Product
11.6.3.3.2 Argentina: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
11.6.3.3.3 Argentina: Opioids Market Breakdown, by Extended Release Long-Acting Opioid
11.6.3.3.4 Argentina: Opioids Market Breakdown, by Application
11.6.3.3.5 Argentina: Opioids Market Breakdown, by Route Of Administration
11.6.3.3.6 Argentina: Opioids Market Breakdown, by Distribution Channel
11.6.3.4 Rest of South and Central America: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
11.6.3.4.1 Rest of South and Central America: Opioids Market Breakdown, by Product
11.6.3.4.2 Rest of South and Central America: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
11.6.3.4.3 Rest of South and Central America: Opioids Market Breakdown, by Extended Release Long Acting Opioid
11.6.3.4.4 Rest of South and Central America: Opioids Market Breakdown, by Application
11.6.3.4.5 Rest of South and Central America: Opioids Market Breakdown, by Route Of Administration
11.6.3.4.6 Rest of South and Central America: Opioids Market Breakdown, by Distribution Channel
12. Industry Landscape
12.1 Overview
12.2 Growth Strategies in Opioids Market
12.3 Organic Growth Strategies
12.3.1 Overview
12.4 Inorganic Growth Strategies
12.4.1 Overview
13. Company Profiles
13.1 Purdue Pharma LP
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Endo International plc
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Mallinckrodt Plc
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Collegium Pharmaceutical Inc
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Neuraxpharm Pharmaceuticals SL
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Hikma Pharmaceuticals Plc
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Mayne Pharma Group Ltd
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Rusan Pharma Ltd
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Trevena Inc
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Teva Pharmaceutical Industries Ltd
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 About the Research Team
14.2 Glossary of Terms

Table 1. Opioids Market Segmentation
Table 2. Opioids Market – Revenue and Forecast to 2030 (US$ Million)
Table 3. Opioids Market – Revenue and Forecast to 2030 (US$ Million) – by Product
Table 4. Global Opioids Market – Revenue and Forecast to 2030 (US$ Million) – by Immediate Release Short Acting Opioid
Table 5. Global Opioids Market – Revenue and Forecast to 2030 (US$ Million) – by Extended Release Long-Acting Opioid
Table 6. Opioids Market – Revenue and Forecast to 2030 (US$ Million) – by Application
Table 7. Opioids Market – Revenue and Forecast to 2030 (US$ Million) – by Route of Administration
Table 8. Opioids Market – Revenue and Forecast to 2030 (US$ Million) – by Distribution Channel
Table 9. North America: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Product
Table 10. North America: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Immediate Release Short Acting Opioid
Table 11. North America: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Extended Release Long-Acting Opioid
Table 12. North America: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Application
Table 13. North America: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Route of Administration
Table 14. North America: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 15. North America: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Country
Table 16. United States: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Product
Table 17. United States: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Immediate Release Short Acting Opioid
Table 18. United States: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Extended Release Long-Acting Opioid
Table 19. United States: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Application
Table 20. United States: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Route of Administration
Table 21. United States: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 22. Canada: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Product
Table 23. Canada: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Immediate Release Short Acting Opioid
Table 24. Canada: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Extended Release Long-Acting Opioid
Table 25. Canada: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Application
Table 26. Canada: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Route of Administration
Table 27. Canada: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 28. Mexico: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Product
Table 29. Mexico: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Immediate Release Short Acting Opioid
Table 30. Mexico: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Extended Release Long-Acting Opioid
Table 31. Mexico: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Application
Table 32. Mexico: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Route of Administration
Table 33. Mexico: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 34. Europe: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Product
Table 35. Europe: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Immediate Release Short Acting Opioid
Table 36. Europe: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Extended Release Long-Acting Opioid
Table 37. Europe: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Application
Table 38. Europe: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Route of Administration
Table 39. Europe: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 40. Europe: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Country
Table 41. United Kingdom: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Product
Table 42. United Kingdom: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Immediate Release Short Acting Opioid
Table 43. United Kingdom: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Extended Release Long-Acting Opioid
Table 44. United Kingdom: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Application
Table 45. United Kingdom: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Route of Administration
Table 46. United Kingdom: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 47. Germany: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Product
Table 48. Germany: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Immediate Release Short Acting Opioid
Table 49. Germany: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Extended Release Long-Acting Opioid
Table 50. Germany: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Application
Table 51. Germany: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Route of Administration
Table 52. Germany: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 53. France: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Product
Table 54. France: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Immediate Release Short Acting Opioid
Table 55. France: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Extended Release Long-Acting Opioid
Table 56. France: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Application
Table 57. France: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Route of Administration
Table 58. France: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 59. Italy: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Product
Table 60. Italy: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Immediate Release Short Acting Opioid
Table 61. Italy: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Extended Release Long-Acting Opioid
Table 62. Italy: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Application
Table 63. Italy: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Route of Administration
Table 64. Italy: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 65. Spain: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Product
Table 66. Spain: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Immediate Release Short Acting Opioid
Table 67. Spain: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Extended Release Long-Acting Opioid
Table 68. Spain: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Application
Table 69. Spain: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Route of Administration
Table 70. Spain: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 71. Rest of Europe: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Product
Table 72. Rest of Europe: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Immediate Release Short Acting Opioid
Table 73. Rest of Europe: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Extended Release Long-Acting Opioid
Table 74. Rest of Europe: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Application
Table 75. Rest of Europe: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Route of Administration
Table 76. Rest of Europe: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 77. Asia Pacific: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Product
Table 78. Asia Pacific: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Immediate Release Short Acting Opioid
Table 79. Asia Pacific: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Extended Release Long-Acting Opioid
Table 80. Asia Pacific: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Application
Table 81. Asia Pacific: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Route of Administration
Table 82. Asia Pacific: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 83. Asia Pacific: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Country
Table 84. China: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Product
Table 85. China: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Immediate Release Short Acting Opioid
Table 86. China: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Extended Release Long-Acting Opioid
Table 87. China: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Application
Table 88. China: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Route of Administration
Table 89. China: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 90. Japan: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Product
Table 91. Japan: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Immediate Release Short Acting Opioid
Table 92. Japan: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Extended Release Long-Acting Opioid
Table 93. Japan: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Application
Table 94. Japan: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Route of Administration
Table 95. Japan: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 96. India: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Product
Table 97. India: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Immediate Release Short Acting Opioid
Table 98. India: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Extended Release Long-Acting Opioid
Table 99. India: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Application
Table 100. India: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Route of Administration
Table 101. India: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 102. South Korea: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Product
Table 103. South Korea: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Immediate Release Short Acting Opioid
Table 104. South Korea: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Extended Release Long-Acting Opioid
Table 105. South Korea: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Application
Table 106. South Korea: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Route of Administration
Table 107. South Korea: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 108. Australia: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Product
Table 109. Australia: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Immediate Release Short Acting Opioid
Table 110. Australia: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Extended Release Long-Acting Opioid
Table 111. Australia: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Application
Table 112. Australia: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Route of Administration
Table 113. Australia: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 114. Rest of APAC: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Product
Table 115. Rest of APAC: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Immediate Release Short Acting Opioid
Table 116. Rest of APAC: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Extended Release Long-Acting Opioid
Table 117. Rest of APAC: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Application
Table 118. Rest of APAC: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Route of Administration
Table 119. Rest of APAC: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 120. Middle East and Africa: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Product
Table 121. Middle East and Africa: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Immediate Release Short Acting Opioid
Table 122. Middle East and Africa: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Extended Release Long-Acting Opioid
Table 123. Middle East and Africa: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Application
Table 124. Middle East and Africa: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Route of Administration
Table 125. Middle East and Africa: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 126. Middle East and Africa: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Country
Table 127. Saudi Arabia: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Product
Table 128. Saudi Arabia: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Immediate Release Short Acting Opioid
Table 129. Saudi Arabia: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Extended Release Long Acting Opioid
Table 130. Saudi Arabia: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Application
Table 131. Saudi Arabia: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Route Of Administration
Table 132. Saudi Arabia: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 133. South Africa: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Product
Table 134. South Africa: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Immediate Release Short Acting Opioid
Table 135. South Africa: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Extended Release Long Acting Opioid
Table 136. South Africa: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Application
Table 137. South Africa: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Route Of Administration
Table 138. South Africa: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 139. United Arab Emirates: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Product
Table 140. United Arab Emirates: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Immediate Release Short Acting Opioid
Table 141. United Arab Emirates: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Extended Release Long Acting Opioid
Table 142. United Arab Emirates: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Application
Table 143. United Arab Emirates: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Route Of Administration
Table 144. United Arab Emirates: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 145. Rest of Middle East and Africa: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Product
Table 146. Rest of Middle East and Africa: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Immediate Release Short Acting Opioid
Table 147. Rest of Middle East and Africa: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Extended Release Long Acting Opioid
Table 148. Rest of Middle East and Africa: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Application
Table 149. Rest of Middle East and Africa: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Route Of Administration
Table 150. Rest of Middle East and Africa: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 151. South and Central America: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Product
Table 152. South and Central America: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Immediate Release Short Acting Opioid
Table 153. South and Central America: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Extended Release Long Acting Opioid
Table 154. South and Central America: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Application
Table 155. South and Central America: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Route Of Administration
Table 156. South and Central America: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 157. South and Central America: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Country
Table 158. Brazil: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Product
Table 159. Brazil: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Immediate Release Short Acting Opioid
Table 160. Brazil: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Extended Release Long Acting Opioid
Table 161. Brazil: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Application
Table 162. Brazil: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Route Of Administration
Table 163. Brazil: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 164. Argentina: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Product
Table 165. Argentina: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Immediate Release Short Acting Opioid
Table 166. Argentina: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Extended Release Long-Acting Opioid
Table 167. Argentina: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Application
Table 168. Argentina: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Route Of Administration
Table 169. Argentina: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 170. Rest of South and Central America: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Product
Table 171. Rest of South and Central America: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Immediate Release Short Acting Opioid
Table 172. Rest of South and Central America: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Extended Release Long Acting Opioid
Table 173. Rest of South and Central America: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Application
Table 174. Rest of South and Central America: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Route Of Administration
Table 175. Rest of South and Central America: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 176. Recent Organic Growth Strategies in Opioids Market
Table 177. Recent Inorganic Growth Strategies in the Opioids Market
Table 178. Glossary of Terms, Opioids Market

Figure 1. Opioids Market Segmentation, by Geography
Figure 2. PEST Analysis
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Opioids Market Revenue (US$ Million), 2022–2030
Figure 5. Opioids Market Breakdown by Geography, 2022 and 2030 (%)
Figure 6. Opioids Market Share (%) – by Product (2022 and 2030)
Figure 7. Immediate Release Short Acting Opioid: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
Figure 8. Extended Release Long-Acting Opioid: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
Figure 9. Opioids Market Share (%) – by Application (2022 and 2030)
Figure 10. Pain Management: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
Figure 11. Anesthesia: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
Figure 12. Diarrhoea Suppression: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
Figure 13. Cough Suppression: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
Figure 14. De-Addiction: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
Figure 15. Others: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
Figure 16. Opioids Market Share (%) – by Route of Administration (2022 and 2030)
Figure 17. Oral: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
Figure 18. Injectable: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
Figure 19. Transdermal Patch: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
Figure 20. Opioids Market Share (%) – by Distribution Channel (2022 and 2030)
Figure 21. Hospital Pharmacies: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
Figure 22. Retail Pharmacies: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
Figure 23. Opioids Market Breakdown by Region, 2022 and 2030 (%)
Figure 24. North America: Opioids Market – Revenue and Forecast to 2030(US$ Million)
Figure 25. North America: Opioids Market Breakdown, by Route of Administration (2022 and 2030)
Figure 26. North America: Opioids Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 27. United States: Opioids Market – Revenue and Forecast to 2030(US$ Million)
Figure 28. Canada: Opioids Market – Revenue and Forecast to 2030(US$ Million)
Figure 29. Mexico: Opioids Market – Revenue and Forecast to 2030(US$ Million)
Figure 30. Europe: Opioids Market – Revenue and Forecast to 2030(US$ Million)
Figure 31. Europe: Opioids Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 32. United Kingdom: Opioids Market – Revenue and Forecast to 2030(US$ Million)
Figure 33. Germany: Opioids Market – Revenue and Forecast to 2030(US$ Million)
Figure 34. France: Opioids Market – Revenue and Forecast to 2030(US$ Million)
Figure 35. Italy: Opioids Market – Revenue and Forecast to 2030(US$ Million)
Figure 36. Spain: Opioids Market – Revenue and Forecast to 2030(US$ Million)
Figure 37. Rest of Europe: Opioids Market – Revenue and Forecast to 2030(US$ Million)
Figure 38. Asia Pacific: Opioids Market – Revenue and Forecast to 2030(US$ Million)
Figure 39. Asia Pacific: Opioids Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 40. China: Opioids Market – Revenue and Forecast to 2030(US$ Million)
Figure 41. Japan: Opioids Market – Revenue and Forecast to 2030(US$ Million)
Figure 42. India: Opioids Market – Revenue and Forecast to 2030(US$ Million)
Figure 43. South Korea: Opioids Market – Revenue and Forecast to 2030(US$ Million)
Figure 44. Australia: Opioids Market – Revenue and Forecast to 2030(US$ Million)
Figure 45. Rest of APAC: Opioids Market – Revenue and Forecast to 2030(US$ Million)
Figure 46. Middle East and Africa: Opioids Market – Revenue and Forecast to 2030(US$ Million)
Figure 47. Saudi Arabia: Opioids Market – Revenue and Forecast to 2030(US$ Million)
Figure 48. South Africa: Opioids Market – Revenue and Forecast to 2030(US$ Million)
Figure 49. United Arab Emirates: Opioids Market – Revenue and Forecast to 2030(US$ Million)
Figure 50. Rest of Middle East and Africa: Opioids Market – Revenue and Forecast to 2030(US$ Million)
Figure 51. South and Central America: Opioids Market – Revenue and Forecast to 2030(US$ Million)
Figure 52. South and Central America: Opioids Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 53. Brazil: Opioids Market – Revenue and Forecast to 2030(US$ Million)
Figure 54. Argentina: Opioids Market – Revenue and Forecast to 2030(US$ Million)
Figure 55. Rest of South and Central America: Opioids Market – Revenue and Forecast to 2030(US$ Million)
Figure 56. Growth Strategies in Opioids Market